⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Rachel RutishauserPH.D.

Infectious Disease · San Francisco, CA 94110

NPI: 1891085833

Share:

33

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

163

Total Claims

$163K

Drug Cost

0

Beneficiaries

$0

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 5,387 Infectious Disease providers

+41%

Brand preference vs peers

30.1% vs 21.3% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

16.6%

Opioid Rate

27

Opioid Claims

$657

Opioid Cost

51.9%

Long-Acting Rate

Brand vs Generic

70% generic

Brand: 49 claims · $143K

Generic: 114 claims · $20K

Patient Profile

62

Avg Age

Female

1.42

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About